Cathflo Activase
Alteplase
Listed by Genentech, Inc.
- Strength
- 2.2 mg/2mL
- Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
What it contains
- Alteplase 2.2 mg/2mL
FDA record
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Intravenous |
| Approval route | BLA — biologic licence |
| NDC code | 50242-041 |
| FDA application | BLA103172 |
| Package sizes listed | 2 |
| Marketed since | September 2001 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.